Skin manifestations of primary immune deficiency

Clinical Reviews in Allergy and Immunology

Volumn 46, Issue 2, 2014, Pages 112-119

  Lehman, Heather ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

Chronic granulomatous disease; Chronic mucocutaneous candidiasis; Ectodermal dysplasia; Erythroderma; Immunologic deficiency syndromes; Infectious skin diseases

Indexed keywords

CD18 ANTIGEN; COMPLEMENT COMPONENT C1; COMPLEMENT COMPONENT C2; COMPLEMENT COMPONENT C4; DECTIN 1; INTERLEUKIN 17;

ATAXIA TELANGIECTASIA; ATOPY; BACTERIAL INFECTION; CELLULAR IMMUNODEFICIENCY; CEREBELLAR ATAXIA; CHEDIAK HIGASHI SYNDROME; DIFFERENTIAL DIAGNOSIS; DYSKERATOSIS CONGENITA; DYSPLASIA; ECTODERMAL DYSPLASIA; ECZEMA; ERYTHRODERMA; HAIR DYSPLASIA; HUMAN; IMMUNE DEFICIENCY; IMMUNOPATHOLOGY; IPEX SYNDROME; MYCOSIS; NAIL DYSPLASIA; NETHERTON DISEASE; PRIMARY IMMUNE DEFICIENCY DISEASE; REVIEW; SKIN DEFECT; SKIN DYSPLASIA; SKIN GRANULOMA; SKIN MANIFESTATION; VASCULITIS; VIRUS INFECTION; WISKOTT ALDRICH SYNDROME;

ANIMALS; AUTOIMMUNITY; DIAGNOSIS, DIFFERENTIAL; EARLY DIAGNOSIS; HUMANS; IMMUNOLOGIC DEFICIENCY SYNDROMES; SKIN; SKIN DISEASES;

EID: 84896548526     PISSN: 10800549     EISSN: 15590267     Source Type: Journal    
DOI: 10.1007/s12016-013-8377-8     Document Type: Review

References (69)

1. Al-Herz W, Bousfiha A, Casanova JL, Chapel H, Conley ME, Cunningham-Rundles C et al (2011) Primary immunodeficiency diseases: an update on the classification from the international union of immunological societies expert committee for primary immunodeficiency. Front Immunol 2:54
2. Berron-Ruiz A, Berron-Perez R, Ruiz-Maldonado R (2000) Cutaneous markers of primary immunodeficiency diseases in children. Pediatr Dermatol 17:91-96 (Pubitemid 30655534)
3. Moin A, Farhoudi A, Moin M, Pourpak Z, Bazargan N (2006) Cutaneous manifestations of primary immunodeficiency diseases in children. Iran J Allergy Asthma Immunol 5:121-126 (Pubitemid 44577196)
4. Al-Herz W, Nanda A (2011) Skin manifestations in primary immunodeficient children. Pediatr Dermatol 28:494-501
5. Joshi AY, Iyer VN, Hagan JB, St Sauver JL, Boyce TG (2009) Incidence and temporal trends of primary immunodeficiency: a population-based cohort study. Mayo Clin Proc 84:16-22
6. Stinchcombe J, Bossi G, Griffiths GM (2004) Linking albinism and immunity: the secrets of secretory lysosomes. Science 305:55-59 (Pubitemid 38869367)
7. Boxer LA, Newburger PE (2007) A molecular classification of congenital neutropenia syndromes. Pediatr Blood Cancer 49:609-614 (Pubitemid 350194422)
8. Fontana S, Parolini S, Vermi W, Booth S, Gallo F, Donini M et al (2006) Innate immunity defects in Hermansky-Pudlak type 2 syndrome. Blood 107:4857-4864 (Pubitemid 43882638)
9. Enders A, Zieger B, Schwarz K, Yoshimi A, Speckmann C, Knoepfle EM et al (2006) Lethal hemophagocytic lymphohistiocytosis in Hermansky-Pudlak syndrome type II. Blood 108:81-87 (Pubitemid 43990615)
10. Spritz RA (1999) Multi-organellar disorders of pigmentation: tied up in traffic. Clin Genet 55:309-317
11. Shaw TE, Currie GP, Koudelka CW, Simpson EL (2011) Eczema prevalence in the United States: data from the 2003 National Survey of Children's Health. J Invest Dermatol 131:67-73
12. Chu EY, Freeman AF, Jing H, Cowen EW, Davis J, Su HC et al (2012) Cutaneous manifestations of DOCK8 deficiency syndrome. Arch Dermatol 148:79-84
13. Freeman AF, Holland SM (2009) Clinical manifestations, etiology, and pathogenesis of the hyper-IgE syndromes. Pediatr Res 65:32R-37R
14. Sullivan KE, Mullen CA, Blaese RM, Winkelstein JA (1994) A multiinstitutional survey of the Wiskott-Aldrich syndrome. J Pediatr 125:876-885 (Pubitemid 24379120)
15. Powell BR, Buist NR, Stenzel P (1982) An X-linked syndrome of diarrhea, polyendocrinopathy, and fatal infection in infancy. J Pediatr 100:731-737 (Pubitemid 12155977)
16. Marrella V, Maina V, Villa A (2011) Omenn syndrome does not live by V(D)J recombination alone. Curr Opin Allergy Clin Immunol 11:525-531
17. Chavanas S, Bodemer C, Rochat A, Hamel-Teillac D, Ali M, Irvine AD et al (2000) Mutations in SPINK5, encoding a serine protease inhibitor, cause Netherton syndrome. Nat Genet 25:141-142 (Pubitemid 30394980)
18. Renner ED, Hartl D, Rylaarsdam S, Young ML, Monaco-Shawver L, Kleiner G et al (2009) Comel-Netherton syndrome defined as primary immunodeficiency. J Allergy Clin Immunol 124:536-543
19. Sehgal VN, Srivastava G, Sardana K (2004) Erythroderma/exfoliative dermatitis: a synopsis. Int J Dermatol 43:39-47 (Pubitemid 38180584)
20. Al-Dhalimi MA (2007) Neonatal and infantile erythroderma: a clinical and follow-up study of 42 cases. J Dermatol 34:302-307 (Pubitemid 46535950)
21. Hoeger PH, Harper JI (1998) Neonatal erythroderma: differential diagnosis and management of the "red baby". Arch Dis Child 79:186-191 (Pubitemid 28384860)
22. Traupe H (1989) The Comèl-Netherton syndrome. The Ichthyoses: Springer Berlin, Heidelberg, pp 168-178
23. de Saint-Basile G, Le Deist F, de Villartay JP, Cerf-Bensussan N, Journet O, Brousse N et al (1991) Restricted heterogeneity of T lymphocytes in combined immunodeficiency with hypereosinophilia (Omenn's syndrome). J Clin Invest 87:1352-1359
24. Le Deist F, Raffoux C, Griscelli C, Fischer A (1987) Graft vs graft reaction resulting in the elimination of maternal cells in a SCID patient with maternofetal GVHd after an HLA identical bone marrow transplantation. J Immunol 138:423-427 (Pubitemid 17002199)
25. Anderson KC, Weinstein HJ (1990) Transfusion-associated graft-versus-host disease. N Engl J Med 323:315-321 (Pubitemid 20237097)
26. Wen L, Atkinson JP, Giclas PC (2004) Clinical and laboratory evaluation of complement deficiency. J Allergy Clin Immunol 113:585-593, quiz 594
27. Arunachalam M, Sanzo M, Lotti T, Colucci R, Berti S, Moretti S (2010) Common variable immunodeficiency in vitiligo. G Ital Dermatol Venereol 145:783-788
28. Spickett G, Prentice AG, Wallington T, Webster AD, Chapel H (1991) Alopecia totalis and vitiligo in common variable immunodeficiency. Postgrad Med J 67:291-294
29. Koskinen S (1996) Long-term follow-up of health in blood donors with primary selective IgA deficiency. J Clin Immunol 16:165-170
30. Ahonen P, Myllarniemi S, Sipila I, Perheentupa J (1990) Clinical variation of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) in a series of 68 patients. N Engl J Med 322:1829-1836 (Pubitemid 20200407)
31. Dupuis-Girod S, Medioni J, Haddad E, Quartier P, Cavazzana-Calvo M, Le Deist F et al (2003) Autoimmunity in Wiskott-Aldrich syndrome: risk factors, clinical features, and outcome in a single-center cohort of 55 patients. Pediatrics 111:e622-e627
32. Catucci M, Castiello MC, Pala F, Bosticardo M, Villa A (2012) Autoimmunity in wiskott-Aldrich syndrome: an unsolved enigma. Front Immunol 3:209
33. Dohil M, Prendiville JS, Crawford RI, Speert DP (1997) Cutaneous manifestations of chronic granulomatous disease. A report of four cases and review of the literature. J Am Acad Dermatol 36:899-907 (Pubitemid 27265898)
34. Cunningham-Rundles C, Bodian C (1999) Common variable immunodeficiency: clinical and immunological features of 248 patients. Clin Immunol 92:34-48 (Pubitemid 29315984)
35. Fasano MB, Sullivan KE, Sarpong SB, Wood RA, Jones SM, Johns CJ et al (1996) Sarcoidosis and common variable immunodeficiency. Report of 8 cases and review of the literature. Medicine (Baltimore) 75:251-261 (Pubitemid 26337845)
36. Warnatz K, Denz A, Drager R, Braun M, Groth C, Wolff-Vorbeck G et al (2002) Severe deficiency of switched memory B cells (CD27(+)IgM(-)IgD(-)) in subgroups of patients with common variable immunodeficiency: a new approach to classify a heterogeneous disease. Blood 99:1544-1551 (Pubitemid 34533024)
37. Piqueras B, Lavenu-Bombled C, Galicier L, Bergeron-van der Cruyssen F, Mouthon L, Chevret S et al (2003) Common variable immunodeficiency patient classification based on impaired B cell memory differentiation correlates with clinical aspects. J Clin Immunol 23:385-400 (Pubitemid 37083193)
38. Sanchez-Ramon S, Radigan L, Yu JE, Bard S, Cunningham-Rundles C (2008) Memory B cells in common variable immunodeficiency: clinical associations and sex differences. Clin Immunol 128:314-321
39. Collins SM, Dominguez M, Ilmarinen T, Costigan C, Irvine AD (2006) Dermatological manifestations of autoimmune polyendocrinopathy-candidiasis- ectodermal dystrophy syndrome. Br J Dermatol 154:1088-1093 (Pubitemid 43727389)
40. Hanson EP, Monaco-Shawver L, Solt LA, Madge LA, Banerjee PP, May MJ et al (2008) Hypomorphic nuclear factor-kappaB essential modulator mutation database and reconstitution system identifies phenotypic and immunologic diversity. J Allergy Clin Immunol 122(1169-1177):e1116
41. Courtois G, Smahi A, Reichenbach J, Doffinger R, Cancrini C, Bonnet M et al (2003) A hypermorphic IkappaBalpha mutation is associated with autosomal dominant anhidrotic ectodermal dysplasia and T cell immunodeficiency. J Clin Invest 112:1108-1115 (Pubitemid 38056325)
42. Notarangelo LD, Roifman CM, Giliani S (2008) Cartilage-hair hypoplasia: molecular basis and heterogeneity of the immunological phenotype. Curr Opin Allergy Clin Immunol 8:534-539
43. Savage SA, Bertuch AA (2010) The genetics and clinical manifestations of telomere biology disorders. Genet Med 12:753-764
44. Dokal I (2011) Dyskeratosis congenita. Hematol Am Soc Hematol Educ Program 2011:480-486
45. Knight SW, Heiss NS, Vulliamy TJ, Aalfs CM, McMahon C, Richmond P et al (1999) Unexplained aplastic anaemia, immunodeficiency, and cerebellar hypoplasia (Hoyeraal-Hreidarsson syndrome) due to mutations in the dyskeratosis congenita gene, DKC1. Br J Haematol 107:335-339 (Pubitemid 29530220)
46. Toomes C, James J, Wood AJ, Wu CL, McCormick D, Lench N et al (1999) Loss-of-function mutations in the cathepsin C gene result in periodontal disease and palmoplantar keratosis. Nat Genet 23:421-424
47. Winkelstein JA, Marino MC, Johnston RB Jr, Boyle J, Curnutte J, Gallin JI et al (2000) Chronic granulomatous disease. Report on a national registry of 368 patients. Medicine (Baltimore) 79:155-169 (Pubitemid 30327530)
48. Windhorst DB, Good RA (1971) Dermatologic manifestations of fatal granulomatous disease of childhood. Arch Dermatol 103:351-357
49. Nord KM, Pappert AS, Grossman ME (2011) Pyoderma gangrenosum-like lesions in leukocyte adhesion deficiency I treated with intravenous immunoglobulin. Pediatr Dermatol 28:156-161
50. Hinze CH, Lucky AW, Bove KE, Marsh RA, Bleesing JH, Passo MH (2010) Leukocyte adhesion deficiency type 1 presenting with recurrent pyoderma gangrenosum and flaccid scarring. Pediatr Dermatol 27:500-503
51. Paller AS, Nanda V, Spates C, O'Gorman M (1994) Leukocyte adhesion deficiency: recurrent childhood skin infections. J Am Acad Dermatol 31:316-319 (Pubitemid 24249256)
52. Buckley RH (2001) The hyper-IgE syndrome. Clin Rev Allergy Immunol 20:139-154
53. Renner ED, Puck JM, Holland SM, Schmitt M, Weiss M, Frosch M et al (2004) Autosomal recessive hyperimmunoglobulin E syndrome: a distinct disease entity. J Pediatr 144:93-99 (Pubitemid 38091428)
54. Reichenbach J, Rosenzweig S, Doffinger R, Dupuis S, Holland SM, Casanova JL (2001) Mycobacterial diseases in primary immunodeficiencies. Curr Opin Allergy Clin Immunol 1:503-511
55. Antaya RJ, Gardner ES, Bettencourt MS, Daines M, Denise Y, Uthaisangsook S et al (2001) Cutaneous complications of BCG vaccination in infants with immune disorders: two cases and a review of the literature. Pediatr Dermatol 18:205-209 (Pubitemid 32573700)
56. Holland SM (2010) Chronic granulomatous disease. Clin Rev Allergy Immunol 38:3-10
57. Engelhardt KR, Grimbacher B (2012) Mendelian traits causing susceptibility to mucocutaneous fungal infections in human subjects. J Allergy Clin Immunol 129:294-305, quiz 306-297
58. Al Khatib S, Keles S, Garcia-Lloret M, Karakoc-Aydiner E, Reisli I, Artac H et al (2009) Defects along the T(H)17 differentiation pathway underlie genetically distinct forms of the hyper IgE syndrome. J Allergy Clin Immunol 124:342-348, 348 e341-345
59. Puel A, Cypowyj S, Marodi L, Abel L, Picard C, Casanova JL (2012) Inborn errors of human IL-17 immunity underlie chronic mucocutaneous candidiasis. Curr Opin Allergy Clin Immunol 12:616-622
60. Ferwerda B, Ferwerda G, Plantinga TS, Willment JA, van Spriel AB, Venselaar H et al (2009) Human dectin-1 deficiency and mucocutaneous fungal infections. N Engl J Med 361:1760-1767
61. Liu L, Okada S, Kong XF, Kreins AY, Cypowyj S, Abhyankar A et al (2011) Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis. J Exp Med 208:1635-1648
62. van de Veerdonk FL, Plantinga TS, Hoischen A, Smeekens SP, Joosten LA, Gilissen C et al (2011) STAT1 mutations in autosomal dominant chronic mucocutaneous candidiasis. N Engl J Med 365:54-61
63. Drewniak AA, Gazendam RP, Tool AT, van Houdt M, Jansen MH, van Hamme JL et al (2013) Invasive fungal infection and impaired neutrophil killing in human CARD9 deficiency. Blood 121:2385-2392
64. Glocker EO, Hennigs A, Nabavi M, Schaffer AA, Woellner C, Salzer U et al (2009) A homozygous CARD9 mutation in a family with susceptibility to fungal infections. N Engl J Med 361:1727-1735
65. Puel A, Doffinger R, Natividad A, Chrabieh M, Barcenas-Morales G, Picard C et al (2010) Autoantibodies against IL-17A, IL-17F, and IL-22 in patients with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type I. J Exp Med 207:291-297
66. Chatzipanagiotou S, Takou K, Perogamvros A (1998) Cutaneous purulent aspergillosis in a young man with chronic granulomatous disease. Mycoses 41:379-382 (Pubitemid 29039390)
67. Zhang Q, Davis JC, Lamborn IT, Freeman AF, Jing H, Favreau AJ et al (2009) Combined immunodeficiency associated with DOCK8 mutations. N Engl J Med 361:2046-2055
68. Ramoz N, Rueda LA, Bouadjar B, Montoya LS, Orth G, Favre M (2002) Mutations in two adjacent novel genes are associated with epidermodysplasia verruciformis. Nat Genet 32:579-581 (Pubitemid 35435168)
69. Hernandez PA, Gorlin RJ, Lukens JN, Taniuchi S, Bohinjec J, Francois F et al (2003) Mutations in the chemokine receptor gene CXCR4 are associated with WHIM syndrome, a combined immunodeficiency disease. Nat Genet 34:70-74 (Pubitemid 36548793)